Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics

IF 3.2 3区心理学 Q1 PSYCHOLOGY, CLINICAL

Clinical psychology & psychotherapy Pub Date : 2023-07-02 DOI:10.1002/cpp.2880

Aileen Kucsera, Trisha Suppes, Nancy A. Haug

{"title":"Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics","authors":"Aileen Kucsera, Trisha Suppes, Nancy A. Haug","doi":"10.1002/cpp.2880","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>This study explored the current knowledge, attitudes, and clinical practices regarding psychedelics among mental health professionals in California, where state legislation to decriminalize psychedelics has been proposed.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>Two hundred thirty-seven mental health providers (74% female; mean age 54; 83% White; 46% psychologists) completed a 37-item online survey between November 2021 and February 2022, disseminated through local and state-wide professional organizations in California.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Providers endorsed limited knowledge about the risks and benefits of psychedelic use (<i>M</i> = 4.7 and 5.4, respectively, with 10 = <i>high knowledge</i>) and inadequate knowledge to counsel patients on use (45%). Gaps in knowledge related to psychedelic drug scheduling and current use in clinical research were identified. Providers expressed support for additional psychedelic research (97%), approval of recreational (66%) and medical (91%) psychedelic use, belief in the potential therapeutic benefits of psychedelics (89%), and concerns about safety (33%) and potential psychiatric risks (27%). Results indicated that most providers discuss psychedelic use with patients (73%), yet many do not feel comfortable addressing the effects of use (49%). There were significant correlations between knowledge and attitudes towards psychedelics (<i>r</i> = 0.2, <i>p</i> = .006; <i>r</i> = 0.31, <i>p</i> < .001) and attitudes and clinical practices (<i>r</i> = 0.34, <i>p</i> < .001).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Findings suggest that providers are interested in psychedelic-assisted treatments and hold favourable attitudes towards the therapeutic use of psychedelics yet lack the knowledge to appropriately counsel patients, highlighting the need for additional provider education about psychedelics.</p>\n </section>\n </div>","PeriodicalId":10460,"journal":{"name":"Clinical psychology & psychotherapy","volume":"30 6","pages":"1369-1379"},"PeriodicalIF":3.2000,"publicationDate":"2023-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cpp.2880","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical psychology & psychotherapy","FirstCategoryId":"102","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpp.2880","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

This study explored the current knowledge, attitudes, and clinical practices regarding psychedelics among mental health professionals in California, where state legislation to decriminalize psychedelics has been proposed.

Method

Two hundred thirty-seven mental health providers (74% female; mean age 54; 83% White; 46% psychologists) completed a 37-item online survey between November 2021 and February 2022, disseminated through local and state-wide professional organizations in California.

Results

Providers endorsed limited knowledge about the risks and benefits of psychedelic use (M = 4.7 and 5.4, respectively, with 10 = high knowledge) and inadequate knowledge to counsel patients on use (45%). Gaps in knowledge related to psychedelic drug scheduling and current use in clinical research were identified. Providers expressed support for additional psychedelic research (97%), approval of recreational (66%) and medical (91%) psychedelic use, belief in the potential therapeutic benefits of psychedelics (89%), and concerns about safety (33%) and potential psychiatric risks (27%). Results indicated that most providers discuss psychedelic use with patients (73%), yet many do not feel comfortable addressing the effects of use (49%). There were significant correlations between knowledge and attitudes towards psychedelics (r = 0.2, p = .006; r = 0.31, p < .001) and attitudes and clinical practices (r = 0.34, p < .001).

Conclusions

Findings suggest that providers are interested in psychedelic-assisted treatments and hold favourable attitudes towards the therapeutic use of psychedelics yet lack the knowledge to appropriately counsel patients, highlighting the need for additional provider education about psychedelics.

Abstract Image

查看原文本刊更多论文

心理学家和心理治疗师对治疗性使用迷幻药的认识、态度和临床实践。

介绍：本研究探讨了加利福尼亚州心理健康专业人员目前对迷幻药的认识、态度和临床实践，该州已提议立法将迷幻药非刑罪化：237 名心理健康服务提供者（74% 为女性；平均年龄 54 岁；83% 为白人；46% 为心理学家）在 2021 年 11 月至 2022 年 2 月期间完成了一项包含 37 个项目的在线调查，该调查通过加利福尼亚州的地方和全州专业组织进行传播：医疗服务提供者对使用迷幻药的风险和益处的了解有限（M = 4.7 和 5.4，分别为 10 = 高知识），并且没有足够的知识为患者提供使用迷幻药方面的咨询（45%）。此外，还发现了与迷幻药日程安排和目前在临床研究中的使用有关的知识缺口。医疗服务提供者表示支持开展更多的迷幻药研究（97%），批准娱乐性使用（66%）和医疗性使用（91%）迷幻药，相信迷幻药的潜在治疗效果（89%），并担心其安全性（33%）和潜在的精神风险（27%）。结果表明，大多数医疗服务提供者会与病人讨论使用迷幻药的问题（73%），但许多人对使用迷幻药的影响感到不自在（49%）。对迷幻药的认识和态度之间存在明显的相关性（r = 0.2，p = .006；r = 0.31，p 结论：对迷幻药的认识和态度之间存在明显的相关性（r = 0.2，p = .006；r = 0.31，p 结论）：研究结果表明，医疗服务提供者对迷幻药辅助治疗感兴趣，并对迷幻药的治疗使用持赞成态度，但却缺乏相关知识，无法为患者提供适当的咨询，这突出表明医疗服务提供者需要接受更多有关迷幻药的教育。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical psychology & psychotherapy PSYCHOLOGY, CLINICAL-

CiteScore

6.30

自引率

5.60%

发文量

106

期刊介绍： Clinical Psychology & Psychotherapy aims to keep clinical psychologists and psychotherapists up to date with new developments in their fields. The Journal will provide an integrative impetus both between theory and practice and between different orientations within clinical psychology and psychotherapy. Clinical Psychology & Psychotherapy will be a forum in which practitioners can present their wealth of expertise and innovations in order to make these available to a wider audience. Equally, the Journal will contain reports from researchers who want to address a larger clinical audience with clinically relevant issues and clinically valid research.